ADCC |
Antibody-Dependent Cellular Cytotoxicity |
APC |
Antigen-presenting cell |
B6 |
C57BL/6 |
CDC |
Complement-Dependent Cytotoxicity |
CFA |
Complete Freund’s Adjuvant |
CSF |
Cerebrospinal Fluid |
CNS |
Central Nervous System |
CD20 |
Cluster of Differentiation 20 |
CD20dbtg |
Double Transgenic huCD20xHIGR3 Mice |
CD20dbtg1 |
First Double Transgenic Cohort |
CD20dbtg2 |
Second Double Transgenic Cohort |
ddH2O |
Double-distilled water |
EAE |
Experimental Autoimmune Encephalomyelitis |
EDSS |
Expanded Disability Status Scale |
huCD20 |
Anti-human CD20 |
huIgG1 |
Human IgG1 Isotype Control Antibody |
mAb |
Monoclonal Antibody |
MBP |
Myelin Basic Protein |
MP4 |
Myelin Basic Protein/Proteolipid Protein Fusion Protein |
MS |
Multiple Sclerosis |
muIgG2a |
Murine IgG2a Isotype Control Antibody |
NF |
Neurofilament |
NfL |
Neurofilament Light Chain |
OBZ |
Obinutuzumab |
PBS |
Phosphate-Buffered Saline |
PLP |
Proteolipid Protein |
NfL |
Neurofilament Light Chain |
PFA |
Paraformaldehyde |
SPMS |
Secondary Progressive Multiple Sclerosis |
TEM |
Transmission Electron Microscopy |
VLT |
Ventrolateral Tract of the Spinal Cord |
wt |
Wildtype Cohort |